WASHINGTON (Reuters) - It looked bad for Chuck Fleming -- lung cancer had spread through his body. But his oncologist decided to try using a “gene chip” to see which out of a laundry list of chemotherapy options might work best.Nine months later, Fleming is not cured, but he feels well enough to consider playing golf again and his targeted treatments -- a daily pill and a twice-monthly infusion -- do not make him feel weak and nauseated.
